Highly Pathogenic Avian Influenza (HPAI)
FDA’s Response to Ensure Continued Effectiveness of Federal-State Milk Safety System
Topic Paragraphs
Featured Topics
Know When and How to Use Antibiotics, and When to Skip Them
Antibiotics are powerful medications that save countless lives every day. But they’re not the answer for every illness.
FDA Modernization Efforts for Establishing a Unified Human Foods Program
The unified Human Foods Program, a new model and name for field operations and other modernization efforts are now in effect.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Nov 28
Gracie’s Kitchen’s Inc. Recalls Read-To-Eat Products Manufactured Between 11/4 and 11/13/24 Because of Possible Health Risk
Food & Beverages
Nov 27
Handsome Brook Farms Issues Recall of Kirkland Signature Organic Pasture Raised 24-Count Eggs Because of Possible Health Risk
Food & Beverages
Nov 27
4Earth Farms, LLC. Recalls Organic and Conventional Vegetable Medleys and Organic Whole Carrots, Containing Grimmway Farms Carrots, Because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
One Health - Optimal Public Health Outcomes for Humans and Animals in Our Shared Environment
FDA collaborates with stakeholders across disciplines and sectors to promote the health of humans, animals, and the environment.
FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub
The Hub will act as the single point of engagement and connection with outside parties for drug and biological product development.
Recently Published Guidances
Nov 27
Recommended Followup Testing for an Ames-Positive Drug (Active Ingredient) or Metabolite To Support First-in-Human Clinical Trials With Healthy Subjects
Drugs
Nov 27
Use of Circulating Tumor Deoxyribonucleic Acid for Early-Stage Solid Tumor Drug Development; Guidance for Industry; Availability
Nov 26
Assessment of Ovarian Toxicity in Premenopausal Adults During Drug Development for Oncologic Products
Biologics, Drugs